Entourage Health (CVE:ENTG) Reaches New 1-Year Low – Should You Sell?

Entourage Health Corp. (CVE:ENTGGet Free Report) shares reached a new 52-week low during trading on Monday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 21750 shares trading hands. The stock had previously closed at C$0.01.

Entourage Health Price Performance

The firm has a market capitalization of C$3.08 million, a P/E ratio of -0.07 and a beta of 1.08. The firm’s 50-day moving average is C$0.01 and its 200 day moving average is C$0.01. The company has a debt-to-equity ratio of 2,914.72, a quick ratio of 0.91 and a current ratio of 0.10.

About Entourage Health

(Get Free Report)

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.

Read More

Receive News & Ratings for Entourage Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entourage Health and related companies with MarketBeat.com's FREE daily email newsletter.